Try GOLD - Free
Anthem IPO: Do valuations justify growth outlook?
Mint Kolkata
|July 12, 2025
Strong growth momentum Anthem leads in revenue growth...
Anthem Biosciences, an innovation-led contract research, development, and manufacturing organization (CRDMO), is set to launch its ₹3,395-crore initial public offering (IPO) on Monday.
The offer-for-sale (OFS), priced between ₹540 and ₹570 per share, marks a key milestone for the company, which has demonstrated strong revenue growth, international expansion, and improving profitability over the past three years.
Having executed over 8,000 drug development projects for more than 675 clients across 44 countries, Anthem has built a solid position in the new chemical entity (NCE) and new biological entity (NBE) segments.
The company's services cater to over 550 pharmaceutical and biotech clients, primarily in the US, Europe, and Japan. Its core CRDMO segment contributes 81.7% of total revenue, with the rest coming from specialty ingredients.
However, valuation concerns, higher inventory levels, and declining research and development (R&D) intensity may temper enthusiasm. The company's strong growth trajectory is evident, but will investors look past these risks?
This story is from the July 12, 2025 edition of Mint Kolkata.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Kolkata
Mint Kolkata
Arsenal's time might be this season: Michael Owen
The former England and Liverpool player on how the game has changed, Premier League predictions, and the Ballon d'Or
5 mins
October 11, 2025
Mint Kolkata
UPI AutoPay’s endless woes forcing an industry rethink
55-90% of automated payments on UPI AutoPay didn’t go through in Aug, NPCI data shows
2 mins
October 11, 2025
Mint Kolkata
Prosus buys 10% stake in Ixigo parent for ₹1,295 cr
Travel tech platform Ixigo has sold a 10% stake in the company to Dutch investor Prosus for ₹1,295 crore, which it plans to use primarily for investing in artificial intelligence, expanding its hotel business, and acquisitions.
1 min
October 11, 2025
Mint Kolkata
Norms for hazardous chemicals tightened
The government has overhauled more than four-decade-old safety codes that govern the production, handling, and storage of hazardous chemicals, as it seeks to bolster industrial safety and prevent chemical-related mishaps in India.
1 min
October 11, 2025
Mint Kolkata
Silver to stay hot as supply thins amid buyer frenzy
Demand for silver has soared on the back of rising industrial use and investor frenzy, but supply remains constrained.
1 min
October 11, 2025
Mint Kolkata
CaratLane is reshaping the jewellery world
CaratLane has become a household name in fine jewellery. Its recently launched CaratLane Gulnaara, a 73-faceted solitaire crafted for exceptional brilliance is a cut above the rest.
2 mins
October 11, 2025
Mint Kolkata
Investors aren't too excited about TCS's biggest bet
“We are on a journey to become the world’s largest artificial intelligence (AI)-led technology services company,” said Tata Consultancy Services (TCS) Ltd’s chief executive K. Krithivasan in prepared remarks on Thursday after announcing it will spend over $6 billion in about six years to set up data centres.
2 mins
October 11, 2025
Mint Kolkata
Science at the political table
'The Man who Fed India' is a diligent record of India's most impactful agriculture scientist, M.S. Swaminathan
5 mins
October 11, 2025
Mint Kolkata
Inside Mumbai's first crying club
The club seeks to create a safe space where adults can experience the catharsis of weeping with company
4 mins
October 11, 2025
Mint Kolkata
Silver to stay hot as supply thins amid buying frenzy
New mines can’t help, either, Exploring and developing new mines typically takes several years.
1 mins
October 11, 2025
Listen
Translate
Change font size